PG# [004]

Related by string. PG-#. . PG# [003] . PG# [002] . PG# [001] * * PG# rating . rated PG# . PG# Zone . Rated PG# *

Related by context. Frequent words. (Click for all words.) 60 CG# [001] 60 mTOR inhibitor 59 liposomal formulation 59 DB# [003] 58 EP# [003] 57 TG# [001] 56 TRC# 55 humanized monoclonal antibody 55 Small Molecule 55 radiolabeled 55 MORAb 54 PF # [001] 54 Monoclonal Antibody 54 MEK inhibitor 54 TG# [004] 54 ONX 54 SCH # 54 TH# [003] 54 XL# [003] 54 LX# [003] 54 Octreotide 53 anticancer compound 53 BEMA TM Fentanyl 53 humanized anti 53 Bortezomib 53 Panzem R 53 Clinical Trial Results 53 epothilone 53 EndoTAG TM -1 53 PEG SN# 53 Vilazodone 52 ATL# [001] 52 Bicifadine 52 Dx 52 Phase Ib clinical 52 Drug Candidate 52 OncoVEX GM CSF 52 fusion inhibitor 52 Aerosurf 52 HCV protease inhibitor 52 antisense drug 52 Traficet EN 51 IND enabling 51 Pivotal Phase III 51 zileuton 51 pharmacokinetic PK 51 Kevetrin 51 elotuzumab 51 registrational trial 51 GLPG# 51 Amrubicin 51 Azedra 50 chemotherapeutic drug 50 BN# [002] 50 Serdaxin 50 Pivotal Phase 50 Nimotuzumab 50 Hepatitis C HCV 50 T1D 50 Clevudine 50 EOquin 50 Phase IIb trials 50 phase IIa 50 IPLEX 50 Phase III Clinical Trial 50 phase IIb clinical 50 AV# [001] 50 SPD# 49 #I [003] 49 lentiviral vector 49 pharmacokinetics PK 49 ALN TTR# 49 diabetic neuropathic pain 49 Nucleic Acid 49 IND submission 49 Ultra Compact 49 Virtex 5 49 Phase IIa trial 48 Phase Ib 48 PR# [003] 48 receptor agonists 48 Laquinimod 48 Icatibant 48 SmartChip System 48 therapeutic antibody 48 TaqMan R 48 Preclinical studies 48 Mass Spectrometer 48 AX# [001] 48 SG# [002] 48 Natalizumab 48 Biochip 48 Carotid 48 PS# [001] 48 U#A [002] 48 TaqMan 48 Phase 2a trial 48 BLA submission 47 injectable formulation 47 Orphan Drug status 47 SN# [001]

Back to home page